Loading...

David Vera

Title(s)Professor In Residence, Radiology
SchoolHealth Sciences
Phone858-822-2574
vCardDownload vCard

    Collapse Biography 
    Collapse Education and Training
    University of California, DavisPh.D. degree in Biophysics
    University of California, San FranciscoB.S. degree in BiologySchool of Medicine

    Collapse Research 
    Collapse Research Activities and Funding
    MR Solutions Benchtop Cryogen Free Superconducting 1.5T/3.0T Rodent MR Scanner
    NIH S10OD018225Apr 17, 2015 - Apr 16, 2016
    Role: Co-Principal Investigator
    In Vivo Cellular and Molecular Imaging Centers (ICMICs)
    NIH/NCI P50CA128346Sep 23, 2008 - Aug 31, 2014
    Role: Principal Investigator
    In Vivo Cellular and Molecular Imaging Centers (ICMICs)
    NIH/NCI P20CA134224Sep 28, 2007 - Aug 31, 2009
    Role: Principal Investigator
    Workshop on Molecular Imaging Agents
    NIH/NCI R13CA126365Apr 1, 2007 - Mar 31, 2008
    Role: Principal Investigator
    Size-Dependent Uptake of Tc(I)-Labeled RGD Analogs
    NIH/NCI R41CA112797Jan 12, 2005 - Dec 31, 2006
    Role: Principal Investigator
    Workshop on Receptor-Binding Radiotracers 2003
    NIH/NCI R13CA101304Feb 10, 2003 - Jan 31, 2004
    Role: Principal Investigator
    BLOOD POOL CONTRAST AGENTS FOR CT AND MRI
    NIH/NIBIB R01EB002111Apr 1, 2000 - Mar 31, 2005
    Role: Principal Investigator
    BLOOD POOL CONTRAST AGENTS FOR CT AND MRI
    NIH/NCI R01CA082335Apr 1, 2000 - Mar 31, 2004
    Role: Principal Investigator
    RECEPTOR BINDING RADIOTRACER FOR SENTINEL NODE IMAGING
    NIH/NCI R01CA072751Feb 1, 1997 - Jan 31, 2002
    Role: Principal Investigator
    RECEPTOR-BASED RADIOTRACERS FOR CARDIOVASCULAR IMAGING
    NIH/NHLBI R01HL035346Dec 1, 1985 - Nov 30, 1986
    Role: Principal Investigator
    VALIDATION OF A KINETIC MODEL FOR RECEPTOR IMAGING
    NIH/NIDDK R01DK034768Dec 1, 1984 - Mar 31, 1996
    Role: Principal Investigator
    VALIDATION OF A KINETIC MODEL FOR RECEPTOR IMAGING
    NIH/NIADDK R23AM034768Dec 1, 1984 - Nov 30, 1985
    Role: Principal Investigator

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
    List All   |   Timeline
    1. Qin Z, Hoh CK, Olson ES, Jahromi AH, Hall DJ, Barback CV, You YH, Yanagita M, Sharma K, Vera DR. Molecular Imaging of the Glomerulus via Mesangial Cell Uptake of Radiolabeled Tilmanocept. J Nucl Med. 2019 Sep; 60(9):1325-1332. PMID: 30796169.
      View in: PubMed
    2. Vidal-Sicart S, Vera DR, Valdés Olmos RA. Next generation of radiotracers for sentinel lymph node biopsy: What is still necessary to establish new imaging paradigms? Rev Esp Med Nucl Imagen Mol. 2018 Nov - Dec; 37(6):373-379. PMID: 30409688.
      View in: PubMed
    3. Brody AL, Gehlbach D, Garcia LY, Enoki R, Hoh C, Vera D, Kotta KK, London ED, Okita K, Nurmi EL, Seaman LC, Mandelkern MA. Effect of overnight smoking abstinence on a marker for microglial activation: a [11C]DAA1106 positron emission tomography study. Psychopharmacology (Berl). 2018 Dec; 235(12):3525-3534. PMID: 30343364.
      View in: PubMed
    4. Anderson KM, Barback CV, Qin Z, Hall DJ, Hoh CK, Vera DR, McHale MT. Molecular Imaging of endometrial sentinel lymph nodes utilizing fluorescent-labeled Tilmanocept during robotic-assisted surgery in a porcine model. PLoS One. 2018; 13(7):e0197842. PMID: 29965996.
      View in: PubMed
    5. Varasteh Z, Hyafil F, Anizan N, Diallo D, Aid-Launais R, Mohanta S, Li Y, Braeuer M, Steiger K, Vigne J, Qin Z, Nekolla SG, Fabre JE, Döring Y, Le Guludec D, Habenicht A, Vera DR, Schwaiger M. Targeting mannose receptor expression on macrophages in atherosclerotic plaques of apolipoprotein E-knockout mice using 111In-tilmanocept. EJNMMI Res. 2017 Dec; 7(1):40. PMID: 28470406.
      View in: PubMed
    6. Lee HJ, Barback CV, Hoh CK, Qin Z, Kader K, Hall DJ, Vera DR, Kane CJ. Fluorescence-Based Molecular Imaging of Porcine Urinary Bladder Sentinel Lymph Nodes. J Nucl Med. 2017 04; 58(4):547-553. PMID: 28153955.
      View in: PubMed
    7. Mendez N, Liberman A, Corbeil J, Barback C, Viveros R, Wang J, Wang-Rodriguez J, Blair SL, Mattrey R, Vera D, Trogler W, Kummel AC. Assessment of in vivo systemic toxicity and biodistribution of iron-doped silica nanoshells. Nanomedicine. 2017 04; 13(3):933-942. PMID: 27840314.
      View in: PubMed
    8. Rodriguez EA, Wang Y, Crisp JL, Vera DR, Tsien RY, Ting R. New Dioxaborolane Chemistry Enables [(18)F]-Positron-Emitting, Fluorescent [(18)F]-Multimodality Biomolecule Generation from the Solid Phase. Bioconjug Chem. 2016 05 18; 27(5):1390-1399. PMID: 27064381.
      View in: PubMed
    9. Schnabl B, Farshchi-Heydari S, Loomba R, Mattrey RF, Hoh CK, Sirlin CB, Brenner DA, Behling CA, Vera DR. Staging of fibrosis in experimental non-alcoholic steatohepatitis by quantitative molecular imaging in rat models. Nucl Med Biol. 2016 Feb; 43(2):179-87. PMID: 26872443.
      View in: PubMed
    10. Unkart JT, Baker JL, Hosseini A, Hoh CK, Wallace MS, Vera DR, Wallace AM. Comparison of Post-injection Site Pain Between Technetium Sulfur Colloid and Technetium Tilmanocept in Breast Cancer Patients Undergoing Sentinel Lymph Node Biopsy. Ann Surg Oncol. 2015 Dec; 22 Suppl 3:S559-65. PMID: 26275779.
      View in: PubMed
    11. Qin Z, Hoh CK, Hall DJ, Vera DR. A tri-modal molecular imaging agent for sentinel lymph node mapping. Nucl Med Biol. 2015 Dec; 42(12):917-22. PMID: 26320812.
      View in: PubMed
    12. Azad AK, Rajaram MV, Metz WL, Cope FO, Blue MS, Vera DR, Schlesinger LS. ?-Tilmanocept, a New Radiopharmaceutical Tracer for Cancer Sentinel Lymph Nodes, Binds to the Mannose Receptor (CD206). J Immunol. 2015 Sep 01; 195(5):2019-29. PMID: 26202986.
      View in: PubMed
    13. Liss MA, Noguchi J, Lee HJ, Vera DR, Kader AK. Sentinel lymph node biopsy in bladder cancer: Systematic review and technology update. Indian J Urol. 2015 Jul-Sep; 31(3):170-5. PMID: 26166959.
      View in: PubMed
    14. Liss MA, Stroup SP, Qin Z, Hoh CK, Hall DJ, Vera DR, Kane CJ. Robotic-assisted fluorescence sentinel lymph node mapping using multimodal image guidance in an animal model. Urology. 2014 Oct; 84(4):982.e9-14. PMID: 25139676.
      View in: PubMed
    15. Baker JL, Pu M, Tokin CA, Hoh CK, Vera DR, Messer K, Wallace AM. Comparison of [(99m)Tc]tilmanocept and filtered [(99m)Tc]sulfur colloid for identification of SLNs in breast cancer patients. Ann Surg Oncol. 2015 Jan; 22(1):40-5. PMID: 25069859.
      View in: PubMed
    16. Liss MA, Farshchi-Heydari S, Qin Z, Hickey SA, Hall DJ, Kane CJ, Vera DR. Preclinical evaluation of robotic-assisted sentinel lymph node fluorescence imaging. J Nucl Med. 2014 Sep; 55(9):1552-6. PMID: 25024425.
      View in: PubMed
    17. Hosseini A, Baker JL, Tokin CA, Qin Z, Hall DJ, Stupak DG, Hayashi T, Wallace AM, Vera DR. Fluorescent-tilmanocept for tumor margin analysis in the mouse model. J Surg Res. 2014 Aug; 190(2):528-34. PMID: 24923630.
      View in: PubMed
    18. Lajtos I, Czernin J, Dahlbom M, Daver F, Emri M, Farshchi-Heydari S, Forgacs A, Hoh CK, Joszai I, Krizsan AK, Lantos J, Major P, Molnar J, Opposits G, Tron L, Vera DR, Balkay L. Cold wall effect eliminating method to determine the contrast recovery coefficient for small animal PET scanners using the NEMA NU-4 image quality phantom. Phys Med Biol. 2014 Jun 07; 59(11):2727-46. PMID: 24800813.
      View in: PubMed
    19. Nichols B, Qin Z, Yang J, Vera DR, Devaraj NK. 68Ga chelating bioorthogonal tetrazine polymers for the multistep labeling of cancer biomarkers. Chem Commun (Camb). 2014 May 25; 50(40):5215-5217. PMID: 24589653.
      View in: PubMed
    20. Qin Z, Hall DJ, Liss MA, Hoh CK, Kane CJ, Wallace AM, Vera DR. Optimization via specific fluorescence brightness of a receptor-targeted probe for optical imaging and positron emission tomography of sentinel lymph nodes. J Biomed Opt. 2013 Oct; 18(10):101315. PMID: 23958947.
      View in: PubMed
    21. Liberman A, Wu Z, Barback CV, Viveros R, Blair SL, Ellies LG, Vera DR, Mattrey RF, Kummel AC, Trogler WC. Color Doppler ultrasound and gamma imaging of intratumorally injected 500 nm iron-silica nanoshells. ACS Nano. 2013 Jul 23; 7(7):6367-77. PMID: 23802554.
      View in: PubMed
    22. Haubner R, Vera DR, Farshchi-Heydari S, Helbok A, Rangger C, Putzer D, Virgolini IJ. Development of 68Ga-labelled DTPA galactosyl human serum albumin for liver function imaging. Eur J Nucl Med Mol Imaging. 2013 Aug; 40(8):1245-55. PMID: 23579865.
      View in: PubMed
    23. Wallace AM, Han LK, Povoski SP, Deck K, Schneebaum S, Hall NC, Hoh CK, Limmer KK, Krontiras H, Frazier TG, Cox C, Avisar E, Faries M, King DW, Christman L, Vera DR. Comparative evaluation of [(99m)tc]tilmanocept for sentinel lymph node mapping in breast cancer patients: results of two phase 3 trials. Ann Surg Oncol. 2013 Aug; 20(8):2590-9. PMID: 23504141.
      View in: PubMed
    24. Emerson DK, Limmer KK, Hall DJ, Han SH, Eckelman WC, Kane CJ, Wallace AM, Vera DR. A receptor-targeted fluorescent radiopharmaceutical for multireporter sentinel lymph node imaging. Radiology. 2012 Oct; 265(1):186-93. PMID: 22753678.
      View in: PubMed
    25. Tokin CA, Cope FO, Metz WL, Blue MS, Potter BM, Abbruzzese BC, Hartman RD, Joy MT, King DW, Christman LA, Vera DR, Wallace AM. The efficacy of Tilmanocept in sentinel lymph mode mapping and identification in breast cancer patients: a comparative review and meta-analysis of the ??mTc-labeled nanocolloid human serum albumin standard of care. Clin Exp Metastasis. 2012 Oct; 29(7):681-6. PMID: 22729510.
      View in: PubMed
    26. Stroup SP, Kane CJ, Farchshchi-Heydari S, James CM, Davis CH, Wallace AM, Hoh CK, Vera DR. Preoperative sentinel lymph node mapping of the prostate using PET/CT fusion imaging and Ga-68-labeled tilmanocept in an animal model. Clin Exp Metastasis. 2012 Oct; 29(7):673-80. PMID: 22714690.
      View in: PubMed
    27. Ting R, Aguilera TA, Crisp JL, Hall DJ, Eckelman WC, Vera DR, Tsien RY. Fast 18F labeling of a near-infrared fluorophore enables positron emission tomography and optical imaging of sentinel lymph nodes. Bioconjug Chem. 2010 Oct 20; 21(10):1811-9. PMID: 20873712.
      View in: PubMed
    28. Wallace AM, Hoh CK, Limmer KK, Darrah DD, Schulteis G, Vera DR. Sentinel lymph node accumulation of Lymphoseek and Tc-99m-sulfur colloid using a "2-day" protocol. Nucl Med Biol. 2009 Aug; 36(6):687-92. PMID: 19647175.
      View in: PubMed
    29. Wang X, Zhao G, Van S, Jiang N, Yu L, Vera D, Howell SB. Pharmacokinetics and tissue distribution of PGG-paclitaxel, a novel macromolecular formulation of paclitaxel, in nu/nu mice bearing NCI-460 lung cancer xenografts. Cancer Chemother Pharmacol. 2010 Feb; 65(3):515-26. PMID: 19593566.
      View in: PubMed
    30. Shackelford DB, Vasquez DS, Corbeil J, Wu S, Leblanc M, Wu CL, Vera DR, Shaw RJ. mTOR and HIF-1alpha-mediated tumor metabolism in an LKB1 mouse model of Peutz-Jeghers syndrome. Proc Natl Acad Sci U S A. 2009 Jul 07; 106(27):11137-42. PMID: 19541609.
      View in: PubMed
    31. Wu W, Kitamura S, Truong DM, Rieg T, Vallon V, Sakurai H, Bush KT, Vera DR, Ross RS, Nigam SK. Beta1-integrin is required for kidney collecting duct morphogenesis and maintenance of renal function. Am J Physiol Renal Physiol. 2009 Jul; 297(1):F210-7. PMID: 19439520.
      View in: PubMed
    32. Eckelman WC, Vera DR. After bench to bedside: the impact of disease progression, commercial opportunities and available instrumentation on clinical outcome. Nucl Med Biol. 2007 Oct; 34(7):727-8. PMID: 17921023.
      View in: PubMed
    33. Wallace AM, Hoh CK, Darrah DD, Schulteis G, Vera DR. Sentinel lymph node mapping of breast cancer via intradermal administration of Lymphoseek. Nucl Med Biol. 2007 Oct; 34(7):849-53. PMID: 17921035.
      View in: PubMed
    34. Obrzut S, Pham RH, Vera DR, Badran K, Hoha CK. Comparison of lesion-to-cerebellum uptake ratios and standardized uptake values in the evaluation of lung nodules with 18F-FDG PET. Nucl Med Commun. 2007 Jan; 28(1):7-13. PMID: 17159543.
      View in: PubMed
    35. Wallace AM, Hoh CK, Ellner SJ, Darrah DD, Schulteis G, Vera DR. Lymphoseek: a molecular imaging agent for melanoma sentinel lymph node mapping. Ann Surg Oncol. 2007 Feb; 14(2):913-21. PMID: 17146742.
      View in: PubMed
    36. Schöder H, Glass EC, Pecking AP, Harness JK, Wallace AM, Hirnle P, Alberini JL, Vilain D, Larson SM, Hoh CK, Vera DR. Molecular targeting of the lymphovascular system for imaging and therapy. Cancer Metastasis Rev. 2006 Jun; 25(2):185-201. PMID: 16770532.
      View in: PubMed
    37. Wallace AM, Ellner SJ, Méndez J, Hoh CK, Salem CE, Bosch CM, Orahood RC, Vera DR. Minimally invasive sentinel lymph node mapping of the pig colon with Lymphoseek. Surgery. 2006 Feb; 139(2):217-23. PMID: 16455331.
      View in: PubMed
    38. Salem CE, Hoh CK, Wallace AM, Vera DR. A preclinical study of prostate sentinel lymph node mapping with [99mTC]diethylenetetramine pentaacetic acid-mannosyl-dextran. J Urol. 2006 Feb; 175(2):744-8. PMID: 16407043.
      View in: PubMed
    39. Vera DR, Hall DJ, Hoh CK, Gallant P, McIntosh LM, Mattrey RF. Cy5.5-DTPA-galactosyl-dextran: a fluorescent probe for in vivo measurement of receptor biochemistry. Nucl Med Biol. 2005 Oct; 32(7):687-93. PMID: 16243643.
      View in: PubMed
    40. Scheibe PO, Vera DR, Eckelman WC. What is to be gained by imaging the same animal before and after treatment? Nucl Med Biol. 2005 Oct; 32(7):727-32. PMID: 16243648.
      View in: PubMed
    41. Wallace AM, Comstock C, Hoh CK, Vera DR. Breast imaging: a surgeon's prospective. Nucl Med Biol. 2005 Oct; 32(7):781-92. PMID: 16243654.
      View in: PubMed
    42. Eckelman WC, Rohatagi S, Krohn KA, Vera DR. Are there lessons to be learned from drug development that will accelerate the use of molecular imaging probes in the clinic? Nucl Med Biol. 2005 Oct; 32(7):657-62. PMID: 16243639.
      View in: PubMed
    43. Sirlin CB, Vera DR, Corbeil JA, Caballero MB, Buxton RB, Mattrey RF. Gadolinium-DTPA-dextran: a macromolecular MR blood pool contrast agent. Acad Radiol. 2004 Dec; 11(12):1361-9. PMID: 15596374.
      View in: PubMed
    44. Ellner SJ, Méndez J, Vera DR, Hoh CK, Ashburn WL, Wallace AM. Sentinel lymph node mapping of the colon and stomach using lymphoseek in a pig model. Ann Surg Oncol. 2004 Jul; 11(7):674-81. PMID: 15231522.
      View in: PubMed
    45. Kokudo N, Vera DR, Makuuchi M. Clinical application of TcGSA. Nucl Med Biol. 2003 Nov; 30(8):845-9. PMID: 14698788.
      View in: PubMed
    46. Ellner SJ, Hoh CK, Vera DR, Darrah DD, Schulteis G, Wallace AM. Dose-dependent biodistribution of [(99m)Tc]DTPA-mannosyl-dextran for breast cancer sentinel lymph node mapping. Nucl Med Biol. 2003 Nov; 30(8):805-10. PMID: 14698783.
      View in: PubMed
    47. Eckelman WC, Vera DR. From bench to bedside. Nucl Med Biol. 2003 Nov; 30(8):793-4. PMID: 14698781.
      View in: PubMed
    48. Méndez J, Wallace AM, Hoh CK, Vera DR. Detection of gastric and colonic sentinel nodes through endoscopic administration of 99mTc-DTPA-mannosyl-dextran in pigs. J Nucl Med. 2003 Oct; 44(10):1677-81. PMID: 14530486.
      View in: PubMed
    49. Hoh CK, Wallace AM, Vera DR. Preclinical studies of [(99m)Tc]DTPA-mannosyl-dextran . Nucl Med Biol. 2003 Jul; 30(5):457-64. PMID: 12831982.
      View in: PubMed
    50. Wallace AM, Hoh CK, Vera DR, Darrah DD, Schulteis G. Lymphoseek: a molecular radiopharmaceutical for sentinel node detection. Ann Surg Oncol. 2003 Jun; 10(5):531-8. PMID: 12794019.
      View in: PubMed
    51. Kokudo N, Vera DR, Tada K, Koizumi M, Seki M, Matsubara T, Ohta H, Yamaguchi T, Takahashi T, Nakajima T, Muto T. Predictors of successful hepatic resection: prognostic usefulness of hepatic asialoglycoprotein receptor analysis. World J Surg. 2002 Nov; 26(11):1342-7. PMID: 12297928.
      View in: PubMed
    52. Vera DR, Mattrey RF. A molecular CT blood pool contrast agent. Acad Radiol. 2002 Jul; 9(7):784-92. PMID: 12139092.
      View in: PubMed
    53. Vera DR, Wallace AM, Hoh CK. [(99m)Tc]MAG(3)-mannosyl-dextran: a receptor-binding radiopharmaceutical for sentinel node detection. Nucl Med Biol. 2001 Jul; 28(5):493-8. PMID: 11516693.
      View in: PubMed
    54. Vera DR, Eckelman WC. Receptor 1980 and Receptor 2000: twenty years of progress in receptor-binding radiotracers. Nucl Med Biol. 2001 Jul; 28(5):475-6. PMID: 11516690.
      View in: PubMed
    55. Stadalnik RC, Vera DR. The evolution of (99m)Tc-NGA as a clinically useful receptor-binding radiopharmaceutical. Nucl Med Biol. 2001 Jul; 28(5):499-503. PMID: 11516694.
      View in: PubMed
    56. Vera DR, Wallace AM, Hoh CK, Mattrey RF. A synthetic macromolecule for sentinel node detection: (99m)Tc-DTPA-mannosyl-dextran. J Nucl Med. 2001 Jun; 42(6):951-9. PMID: 11390562.
      View in: PubMed
    57. Miki K, Kubota K, Inoue Y, Vera DR, Makuuchi M. Receptor measurements via Tc-GSA kinetic modeling are proportional to functional hepatocellular mass. J Nucl Med. 2001 May; 42(5):733-7. PMID: 11337568.
      View in: PubMed
    58. Colquhoun SD, Connelly CA, Vera DR. Portal-Systemic shunts reduce asialoglycoprotein receptor density in rats. J Nucl Med. 2001 Jan; 42(1):110-6. PMID: 11197958.
      View in: PubMed
    59. Stein M, Vera DR, Stadalnik RC. TIPS reduces hepatic asialoglycoprotein receptor concentration in healthy pigs. J Vasc Interv Radiol. 2000 Jan; 11(1):123-8. PMID: 10693724.
      View in: PubMed
    60. Wallace AM, Vera DR, Stadalnik RC. Blue dye and 99mTc-labeled human serum albumin: sentinel node detection by magic bullets? J Nucl Med. 1999 Jul; 40(7):1149-50. PMID: 10405135.
      View in: PubMed
    61. Kokudo N, Vera DR, Koizumi M, Seki M, Sato T, Stadalnik RC, Takahashi T. Recovery of hepatic asialoglycoprotein receptors after major hepatic resection. J Nucl Med. 1999 Jan; 40(1):137-41. PMID: 9935069.
      View in: PubMed
    62. Vera DR, Wisner ER, Stadalnik RC. Sentinel node imaging via a nonparticulate receptor-binding radiotracer. J Nucl Med. 1997 Apr; 38(4):530-5. PMID: 9098197.
      View in: PubMed
    63. Xu JC, Vera DR, Stadalnik RC. Automatic preparation of radiopharmacokinetic data for in vivo estimation of receptor biochemistry. J Nucl Med. 1996 Nov; 37(11):1896-902. PMID: 8917199.
      View in: PubMed
    64. Vera DR, Stadalnik RC, Metz CE, Pimstone NR. Diagnostic performance of a receptor-binding radiopharmacokinetic model. J Nucl Med. 1996 Jan; 37(1):160-4. PMID: 8543988.
      View in: PubMed
    65. Opsahl LR, Uzgiris EE, Vera DR. Tumor imaging with a macromolecular paramagnetic contrast agent: gadopentetate dimeglumine-polylysine. Acad Radiol. 1995 Sep; 2(9):762-7. PMID: 9419637.
      View in: PubMed
    66. Vera DR, Buonocore MH, Wisner ER, Katzberg RW, Stadalnik RC. A molecular receptor-binding contrast agent for magnetic resonance imaging of the liver. Acad Radiol. 1995 Jun; 2(6):497-506. PMID: 9419597.
      View in: PubMed
    67. Wisner ER, Amparo EG, Vera DR, Brock JM, Barlow TW, Griffey SM, Drake C, Katzberg RW. Arabinogalactan-coated superparamagnetic iron oxide: effect of particle size in liver MRI. J Comput Assist Tomogr. 1995 Mar-Apr; 19(2):211-5. PMID: 7890843.
      View in: PubMed
    68. Pimstone NR, Stadalnik RC, Vera DR, Hutak DP, Trudeau WL. Evaluation of hepatocellular function by way of receptor-mediated uptake of a technetium-99m-labeled asialoglycoprotein analog. Hepatology. 1994 Oct; 20(4 Pt 1):917-23. PMID: 7927233.
      View in: PubMed
    69. Vera DR, Scheibe PO, Banin Y, Stadalnik RC. Local identifiability of a receptor-binding radiopharmacokinetic system having measured parameters of known uncertainty. IEEE Trans Biomed Eng. 1994 Sep; 41(9):891-7. PMID: 7959816.
      View in: PubMed
    70. Vera DR, Topcu SJ, Stadalnik RC. In vitro quantification of asialoglycoprotein receptor density from human hepatic microsamples. Methods Enzymol. 1994; 247:394-402. PMID: 7898367.
      View in: PubMed
    71. Kudo M, Vera DR, Stadalnik RC. In vivo quantification of asialoglycoprotein receptor. Methods Enzymol. 1994; 247:373-82. PMID: 7898365.
      View in: PubMed
    72. Vera DR, Stadalnik RC, Kudo M, Krohn KA. Radiopharmaceutical preparation of technetium-99m-labeled galactosyl neoglycoalbumin. Methods Enzymol. 1994; 247:402-9. PMID: 7898368.
      View in: PubMed
    73. Kudo M, Vera DR, Stadalnik RC, Esquivel CO, Trudeau WL, Ikekubo K, Todo A. Measurement of functioning hepatocyte mass via [99mTc]galactosyl-neoglycoalbumin. Dig Dis Sci. 1993 Dec; 38(12):2183-8. PMID: 8261818.
      View in: PubMed
    74. Kudo M, Todo A, Ikekubo K, Yamamoto K, Vera DR, Stadalnik RC. Quantitative assessment of hepatocellular function through in vivo radioreceptor imaging with technetium 99m galactosyl human serum albumin. Hepatology. 1993 May; 17(5):814-9. PMID: 8491449.
      View in: PubMed
    75. Stadalnik RC, Kudo M, Eckelman WC, Vera DR. In vivo functional imaging using receptor-binding radiopharmaceuticals. Technetium 99m-galactosyl-neoglycoalbumin as a model. Invest Radiol. 1993 Jan; 28(1):64-70. PMID: 8425855.
      View in: PubMed
    76. Vera DR. Gallium-labeled deferoxamine-galactosyl-neoglycoalbumin: a radiopharmaceutical for regional measurement of hepatic receptor biochemistry. J Nucl Med. 1992 Jun; 33(6):1160-6. PMID: 1597732.
      View in: PubMed
    77. Vera DR, Scheibe PO, Krohn KA, Trudeau WL, Stadalnik RC. Goodness-of-fit and local identifiability of a receptor-binding radiopharmacokinetic system. IEEE Trans Biomed Eng. 1992 Apr; 39(4):356-67. PMID: 1592401.
      View in: PubMed
    78. Vera DR, Stadalnik RC, Trudeau WL, Scheibe PO, Krohn KA. Measurement of receptor concentration and forward-binding rate constant via radiopharmacokinetic modeling of technetium-99m-galactosyl-neoglycoalbumin. J Nucl Med. 1991 Jun; 32(6):1169-76. PMID: 2045930.
      View in: PubMed
    79. Kudo M, Vera DR, Trudeau WL, Stadalnik RC. Validation of in vivo receptor measurements via in vitro radioassay: technetium-99m-galactosyl-neoglycoalbumin as prototype model. J Nucl Med. 1991 Jun; 32(6):1177-82. PMID: 2045931.
      View in: PubMed
    80. Kudo M, Vera DR, Trudeau WL, Stadalnik RC. Hepatic uptake of [99mTc]galactosyl-neoglycoalbumin is sensitive to receptor quantity. Int J Rad Appl Instrum B. 1991; 18(7):663-6. PMID: 1787074.
      View in: PubMed
    81. Kudo M, Vera DR, Stadalnik RC, Trudeau WL, Ikekubo K, Todo A. [In vivo measurement of hepatic binding protein in chronic liver disease--validation as a measure of hepatic functional reserve]. Nihon Shokakibyo Gakkai Zasshi. 1991 Jan; 88(1):40-50. PMID: 1851238.
      View in: PubMed
    82. Kudo M, Vera DR, Stadalnik RC, Trudeau WL, Ikekubo K, Todo A. In vivo estimates of hepatic binding protein concentration: correlation with classical indicators of hepatic functional reserve. Am J Gastroenterol. 1990 Sep; 85(9):1142-8. PMID: 2389727.
      View in: PubMed
    83. Vera DR, Woodle ES, Stadalnik RC. Kinetic sensitivity of a receptor-binding radiopharmaceutical: technetium-99m galactosyl-neoglycoalbumin. J Nucl Med. 1989 Sep; 30(9):1519-30. PMID: 2549225.
      View in: PubMed
    84. Woodle ES, Ward RE, Stadalnik RC, Vera DR. Tc-NGA imaging in liver transplantation: preliminary clinical experience. Surgery. 1989 Mar; 105(3):401-7. PMID: 2646744.
      View in: PubMed
    85. Woodle ES, Vera DR, Stadalnik RC, Ward RE. Tc-NGA imaging in liver transplantation: preclinical studies. Surgery. 1987 Jul; 102(1):55-62. PMID: 3296267.
      View in: PubMed
    86. Stadalnik RC, Vera DR, Woodle ES, Trudeau WL, Porter BA, Ward RE, Krohn KA, O'Grady LF. Technetium-99m NGA functional hepatic imaging: preliminary clinical experience. J Nucl Med. 1985 Nov; 26(11):1233-42. PMID: 2997417.
      View in: PubMed
    87. Vera DR, Stadalnik RC, Krohn KA. Technetium-99m galactosyl-neoglycoalbumin: preparation and preclinical studies. J Nucl Med. 1985 Oct; 26(10):1157-67. PMID: 4045560.
      View in: PubMed
    88. Vera DR, Krohn KA, Scheibe PO, Stadalnik RC. Identifiability analysis of an in vivo receptor-binding radiopharmacokinetic system. IEEE Trans Biomed Eng. 1985 May; 32(5):312-22. PMID: 3997184.
      View in: PubMed
    89. Vera DR, Krohn KA, Stadalnik RC, Scheibe PO. Tc-99m galactosyl-neoglycoalbumin: in vitro characterization of receptor-mediated binding. J Nucl Med. 1984 Jul; 25(7):779-87. PMID: 6737077.
      View in: PubMed
    90. Vera DR, Krohn KA, Stadalnik RC, Scheibe PO. Tc-99m-galactosyl-neoglycoalbumin: in vivo characterization of receptor-mediated binding to hepatocytes. Radiology. 1984 Apr; 151(1):191-6. PMID: 6701314.
      View in: PubMed
    91. Stadalnik RC, Matolo NM, Jansholt AL, Vera DR. Clinical experience with 99mTc-disofenin as a cholescintigraphic agent. Radiology. 1981 Sep; 140(3):797-800. PMID: 7025091.
      View in: PubMed